MX2021000215A - Diagnostic assays and kits for detection of folate receptor 1. - Google Patents

Diagnostic assays and kits for detection of folate receptor 1.

Info

Publication number
MX2021000215A
MX2021000215A MX2021000215A MX2021000215A MX2021000215A MX 2021000215 A MX2021000215 A MX 2021000215A MX 2021000215 A MX2021000215 A MX 2021000215A MX 2021000215 A MX2021000215 A MX 2021000215A MX 2021000215 A MX2021000215 A MX 2021000215A
Authority
MX
Mexico
Prior art keywords
folate receptor
detection
diagnostic assays
kits
folri
Prior art date
Application number
MX2021000215A
Other languages
Spanish (es)
Inventor
Nathan E Testa
Olga Ab
Daniel Tavares
Beni B Wolf
CARRIGAN Christina N
Original Assignee
Immunogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunogen Inc filed Critical Immunogen Inc
Priority to MX2021000215A priority Critical patent/MX2021000215A/en
Publication of MX2021000215A publication Critical patent/MX2021000215A/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention generally relates to antibodies that bind to human folate receptor 1 and diagnostic assays for folate receptor 1 -based therapies. Methods of using the antibodies to monitor therapy are further provided. The present invention provides methods for detection of FOLRI in a sample and can be used, for example, to stratify patients. Thus, in one embodiment, the invention provides a method of treating a patient having a folate receptor 1 -mediated disease comprising: (a) measuring the shed folate receptor 1 (FOLRI) expression level or FOLR1 on a circuiting tumor cell (CTC) in a sample taken from a patient.
MX2021000215A 2021-01-07 2021-01-07 Diagnostic assays and kits for detection of folate receptor 1. MX2021000215A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2021000215A MX2021000215A (en) 2021-01-07 2021-01-07 Diagnostic assays and kits for detection of folate receptor 1.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2021000215A MX2021000215A (en) 2021-01-07 2021-01-07 Diagnostic assays and kits for detection of folate receptor 1.

Publications (1)

Publication Number Publication Date
MX2021000215A true MX2021000215A (en) 2022-07-08

Family

ID=88016878

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021000215A MX2021000215A (en) 2021-01-07 2021-01-07 Diagnostic assays and kits for detection of folate receptor 1.

Country Status (1)

Country Link
MX (1) MX2021000215A (en)

Similar Documents

Publication Publication Date Title
SG10201804260QA (en) Diagnostic assays and kits for detection of folate receptor 1
Cella et al. Estimating clinically meaningful changes for the Functional Assessment of Cancer Therapy—Prostate: results from a clinical trial of patients with metastatic hormone-refractory prostate cancer
Irvine et al. A critical appraisal of the research literature investigating fatigue in the individual with cancer
Song et al. DTI measures track and predict motor function outcomes in stroke rehabilitation utilizing BCI technology
Rabago et al. Association between disease-specific quality of life and magnetic resonance imaging outcomes in a clinical trial of prolotherapy for knee osteoarthritis
Marzetti et al. Serum levels of C-terminal agrin fragment (CAF) are associated with sarcopenia in older hip fractured patients
Baird et al. Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease
Testera-Montes et al. Diagnostic tools in allergic rhinitis
Kučukalić-Selimović et al. The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women
Zil-E-Ali et al. Diagnosing necrotizing fasciitis using procalcitonin and a laboratory risk indicator: brief overview
Bahr Hosseini et al. Central nervous system electrical stimulation for neuroprotection in acute cerebral ischemia: meta-analysis of preclinical studies
Liu et al. Serum neuroendocrine markers predict therapy outcome of patients with metastatic castration-resistant prostate cancer: a meta-analysis
Scheytt et al. Increased gene expression of growth associated protein-43 in skin of patients with early-stage peripheral neuropathies
MX2021000215A (en) Diagnostic assays and kits for detection of folate receptor 1.
de Godoy et al. Treatment for chest pain intercurrence after breast cancer surgery using Godoy’s intermittent skin therapy
Aprile et al. Influence of cognitive impairment on the recovery of subjects with subacute stroke undergoing upper limb robotic rehabilitation. Brain Sci. 2021; 11 (5): 587. doi: 10.3390/brainsci11050587.»
Bryuzginova et al. Changes in electrokinetic indices of nuclei in buccal epithelium cells under the influence of millimeter-wave electromagnetic radiation
Selby Age-stratified NT-proBNP Thresholds Identify Acute Heart Failure.
KUMAR et al. PREVALENCE OF HYPOTHYROIDISM IN FEMALES WITH DEPRESSIVE DISORDER.
Mahno et al. Unilateral Adrenal Hyperplasia: A Rare Cause of Primary Aldosteronism
Baidya et al. Cross-cultural translation and validation of the Hindi version of the intermittent and constant osteoarthritis pain scale in knee osteoarthritis patients
Minaeva et al. P1581: DYNAMICS OF NT-PROBNP LEVEL IN UNRELATED DONORS DURING MOBILIZATION OF HEMATOPOIETIC STEM CELLS
Guo et al. Protocol: Effect of transcutaneous electrical acupoint stimulation on bone metabolism in patients with immobilisation after foot and ankle fracture surgery: a randomised controlled trial study protocol
Saponaro et al. SAT-393 Cognitive Function Evaluation in an Italian Cohort of Patients with Post-Operative Hypoparathyroidism
Graves A critical appraisal of" Acute effect of scapular proprioceptive neuromuscular facilitation (PNF) techniques and classic exercises in adhesive capsulitis: a randomized controlled trial"